A Registry of Patients With Primary Indeterminate Lesions or Choroidal Melanoma

Trial ID or NCT#

NCT03941379

Status

recruiting iconRECRUITING

Purpose

The purpose of this observational research study is to follow participants who have been treated with either AU-011 or observation and/or received standard of care therapy while participating in a previous Aura Biosciences clinical research study to assess the long-term safety and effectiveness of AU-011 and standard of care therapy. This study will collect information from procedures conducted as part of routine follow-up eye care and cancer care. Additionally, the registry will collect all adverse events, information about pregnancy and symptomatic overdose.

Official Title

A Registry of Patients With Primary Indeterminate Lesions or Choroidal Melanoma

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - Have been clinically diagnosed with primary IL or CM at the time of entry to a previous Aura Biosciences sponsored clinical trial. - Have received AU-011 or assigned to an observation cohort in a previous Aura sponsored clinical trial.
Exclusion Criteria:
  1. - None

Contact us to find out if this trial is right for you.

CONTACT

Mariana Nunez
mnunez1@stanford.edu